Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Distribute ExonHit s Alternative Splicing Microarrays

NEW YORK, Sept. 1 (GenomeWeb News) - Agilent Technologies will distribute alternative splicing microarrays from ExonHit Therapeutics, the companies said today.


Under the agreement, Agilent will directly sell ExonHit's SpliceArrays to customers, who will also purchase a license agreement from ExonHit, with license fees proportional to the number of arrays bought.


The arrays' probe design allows users to detect both the reference and alternatively spliced forms of targeted genes on Agilent's microarray platform.


The two companies have been collaborating on the arrays since last November. So far, they had only been available through ExonHit's SpliceArray Service, which was announced in February.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.